67/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0. Gray context columns never affect the score. CEO quarterly pay is the explicitly marked annual ÷ 4 estimate.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly. Unavailable evidence scores 0 only in Win/Lose columns; gray columns award no points.
| Quarter | Total return | Revenue growth | EPS growth | Net marginNon-scoring | Trailing P/ENon-scoring | Price/bookNon-scoring | CEO quarterly payNon-scoring | Implied DilutionNon-scoring | Implied BuybackNon-scoring |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q23/3 |
WinCDNA / S&P 64.17% / 15.20% |
WinCDNA / S&P 34.41% / 15.00% |
WinCDNA / S&P 97.14% / 50.40% |
Non-scoringCDNA / S&P 24.23% / 15.70% | Non-scoringCDNA / S&P 13.22 / 28.47 | Non-scoringCDNA / S&P 3.45 / S&P unavailable | Non-scoringCDNA / S&P CDNA unavailable / S&P unavailable | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.36b |
| 2026-Q11/3 |
LoseCDNA / S&P -7.86% / -4.33% |
WinCDNA / S&P 19.17% / 11.30% |
LoseCDNA / S&P -114.29% / 27.70% |
Non-scoringCDNA / S&P -1.98% / 14.80% | Non-scoringCDNA / S&P CDNA unavailable / 25.43 | Non-scoringCDNA / S&P 2.84 / S&P unavailable | Non-scoringCDNA / S&P CDNA unavailable / S&P unavailable | Non-scoringCDNA / S&P CDNA unavailable / $0.27b | Non-scoringCDNA / S&P CDNA unavailable / $0.00b |
| 2025-Q42/3 |
WinCDNA / S&P 29.57% / 2.65% |
WinCDNA / S&P 13.79% / 9.00% |
LoseCDNA / S&P -143.01% / 13.40% |
Non-scoringCDNA / S&P -5.62% / 13.20% | Non-scoringCDNA / S&P CDNA unavailable / 28.48 | Non-scoringCDNA / S&P 3.16 / 5.39 | Non-scoringCDNA / S&P CDNA unavailable / $4.42m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.20b |
| 2025-Q31/3 |
LoseCDNA / S&P -25.59% / 8.12% |
WinCDNA / S&P 14.46% / 4.61% |
LoseCDNA / S&P -144.60% / 13.45% |
Non-scoringCDNA / S&P 19.68% / 11.78% | Non-scoringCDNA / S&P 10.61 / 28.13 | Non-scoringCDNA / S&P 2.40 / 5.27 | Non-scoringCDNA / S&P CDNA unavailable / $4.42m | Non-scoringCDNA / S&P CDNA unavailable / $0.11b | Non-scoringCDNA / S&P CDNA unavailable / $0.00b |
| 2025-Q21/3 |
LoseCDNA / S&P 10.08% / 10.94% |
WinCDNA / S&P 14.72% / 4.83% |
LoseCDNA / S&P -133.87% / 10.63% |
Non-scoringCDNA / S&P 17.06% / 11.45% | Non-scoringCDNA / S&P 17.89 / 27.10 | Non-scoringCDNA / S&P 3.18 / 5.01 | Non-scoringCDNA / S&P CDNA unavailable / $4.42m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.23b |
| 2025-Q11/3 |
LoseCDNA / S&P -17.09% / -4.27% |
WinCDNA / S&P 25.92% / 4.98% |
LoseCDNA / S&P -132.28% / 10.57% |
Non-scoringCDNA / S&P 17.92% / 11.39% | Non-scoringCDNA / S&P 15.86 / 26.23 | Non-scoringCDNA / S&P 2.60 / 4.69 | Non-scoringCDNA / S&P CDNA unavailable / $4.42m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.10b |
| 2024-Q41/3 |
LoseCDNA / S&P -31.43% / 2.41% |
WinCDNA / S&P 19.07% / 5.25% |
LoseCDNA / S&P -126.35% / 6.15% |
Non-scoringCDNA / S&P 15.74% / 11.29% | Non-scoringCDNA / S&P 22.32 / 28.60 | Non-scoringCDNA / S&P 3.10 / 4.99 | Non-scoringCDNA / S&P CDNA unavailable / $4.28m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.08b |
| 2024-Q32/3 |
WinCDNA / S&P 101.06% / 5.89% |
LoseCDNA / S&P 5.26% / 5.89% |
WinCDNA / S&P 70.83% / 6.11% |
Non-scoringCDNA / S&P -49.00% / 10.87% | Non-scoringCDNA / S&P CDNA unavailable / 28.09 | Non-scoringCDNA / S&P 6.07 / 4.94 | Non-scoringCDNA / S&P CDNA unavailable / $4.28m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.21b |
| 2024-Q22/3 |
WinCDNA / S&P 46.65% / 4.28% |
LoseCDNA / S&P -3.95% / 5.38% |
WinCDNA / S&P 97.45% / 5.12% |
Non-scoringCDNA / S&P -55.91% / 10.85% | Non-scoringCDNA / S&P CDNA unavailable / 27.64 | Non-scoringCDNA / S&P 3.09 / 4.79 | Non-scoringCDNA / S&P CDNA unavailable / $4.28m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.36b |
| 2024-Q11/3 |
LoseCDNA / S&P -11.75% / 10.56% |
LoseCDNA / S&P -13.93% / 5.71% |
WinCDNA / S&P 128.29% / 5.59% |
Non-scoringCDNA / S&P -67.76% / 10.81% | Non-scoringCDNA / S&P CDNA unavailable / 27.02 | Non-scoringCDNA / S&P 2.14 / 4.71 | Non-scoringCDNA / S&P CDNA unavailable / $4.28m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.12b |
| 2023-Q42/3 |
WinCDNA / S&P 71.43% / 11.69% |
LoseCDNA / S&P -12.89% / 6.81% |
WinCDNA / S&P 143.45% / 7.78% |
Non-scoringCDNA / S&P -67.88% / 11.19% | Non-scoringCDNA / S&P CDNA unavailable / 24.35 | Non-scoringCDNA / S&P 2.36 / 4.31 | Non-scoringCDNA / S&P CDNA unavailable / $4.08m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.01b |
| 2023-Q31/3 |
LoseCDNA / S&P -17.65% / -3.27% |
LoseCDNA / S&P -6.74% / 7.52% |
WinCDNA / S&P 19.15% / -5.03% |
Non-scoringCDNA / S&P -30.46% / 10.84% | Non-scoringCDNA / S&P CDNA unavailable / 23.93 | Non-scoringCDNA / S&P 0.96 / 3.98 | Non-scoringCDNA / S&P CDNA unavailable / $4.08m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.24b |
| 2023-Q21/3 |
LoseCDNA / S&P -7.00% / 8.74% |
LoseCDNA / S&P -1.76% / 9.50% |
WinCDNA / S&P 18.94% / -8.57% |
Non-scoringCDNA / S&P -27.15% / 10.88% | Non-scoringCDNA / S&P CDNA unavailable / 24.01 | Non-scoringCDNA / S&P 1.13 / 4.19 | Non-scoringCDNA / S&P CDNA unavailable / $4.08m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.17b |
| 2023-Q11/3 |
LoseCDNA / S&P -19.89% / 7.50% |
LoseCDNA / S&P 3.64% / 10.77% |
WinCDNA / S&P 60.00% / -15.69% |
Non-scoringCDNA / S&P -25.25% / 10.82% | Non-scoringCDNA / S&P CDNA unavailable / 22.66 | Non-scoringCDNA / S&P 1.17 / 3.93 | Non-scoringCDNA / S&P CDNA unavailable / $4.08m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.13b |
| 2022-Q41/3 |
LoseCDNA / S&P -32.96% / 7.56% |
LoseCDNA / S&P 8.57% / 11.88% |
WinCDNA / S&P 145.76% / -17.99% |
Non-scoringCDNA / S&P -23.81% / 11.09% | Non-scoringCDNA / S&P CDNA unavailable / 22.65 | Non-scoringCDNA / S&P 1.42 / 3.75 | Non-scoringCDNA / S&P CDNA unavailable / $3.70m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.15b |
| 2022-Q32/3 |
LoseCDNA / S&P -20.76% / -4.88% |
WinCDNA / S&P 15.52% / 13.47% |
WinCDNA / S&P 302.86% / -1.41% |
Non-scoringCDNA / S&P -23.36% / 12.28% | Non-scoringCDNA / S&P CDNA unavailable / 20.58 | Non-scoringCDNA / S&P 2.09 / 3.60 | Non-scoringCDNA / S&P CDNA unavailable / $3.70m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.17b |
| 2022-Q22/3 |
LoseCDNA / S&P -41.93% / -16.10% |
WinCDNA / S&P 24.16% / 13.71% |
WinCDNA / S&P 633.33% / 11.04% |
Non-scoringCDNA / S&P -22.04% / 13.03% | Non-scoringCDNA / S&P CDNA unavailable / 20.28 | Non-scoringCDNA / S&P 2.58 / 3.78 | Non-scoringCDNA / S&P CDNA unavailable / $3.70m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.17b |
| 2022-Q12/3 |
LoseCDNA / S&P -18.67% / -4.60% |
WinCDNA / S&P 39.42% / 15.97% |
WinCDNA / S&P 227.59% / 42.23% |
Non-scoringCDNA / S&P -16.09% / 14.22% | Non-scoringCDNA / S&P CDNA unavailable / 22.19 | Non-scoringCDNA / S&P 4.29 / 4.51 | Non-scoringCDNA / S&P CDNA unavailable / $3.70m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.20b |
| 2021-Q41/3 |
LoseCDNA / S&P -28.23% / 11.03% |
WinCDNA / S&P 54.22% / 15.00% |
LoseCDNA / S&P 40.48% / 96.40% |
Non-scoringCDNA / S&P -10.34% / 15.13% | Non-scoringCDNA / S&P CDNA unavailable / 23.63 | Non-scoringCDNA / S&P 5.17 / 4.73 | Non-scoringCDNA / S&P CDNA unavailable / $3.63m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.13b |
| 2021-Q31/3 |
LoseCDNA / S&P -30.76% / 0.58% |
WinCDNA / S&P 62.85% / 10.77% |
LoseCDNA / S&P -23.91% / 69.42% |
Non-scoringCDNA / S&P -6.54% / 14.13% | Non-scoringCDNA / S&P CDNA unavailable / 25.35 | Non-scoringCDNA / S&P 7.08 / 4.38 | Non-scoringCDNA / S&P CDNA unavailable / $3.63m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.19b |
| 2021-Q22/3 |
WinCDNA / S&P 34.41% / 8.55% |
WinCDNA / S&P 69.28% / 6.58% |
LoseCDNA / S&P -59.09% / 51.81% |
Non-scoringCDNA / S&P -3.53% / 13.34% | Non-scoringCDNA / S&P CDNA unavailable / 26.70 | Non-scoringCDNA / S&P 10.02 / 4.43 | Non-scoringCDNA / S&P CDNA unavailable / $3.63m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.11b |
| 2021-Q11/3 |
LoseCDNA / S&P -6.02% / 6.17% |
WinCDNA / S&P 58.62% / -1.06% |
LoseCDNA / S&P -39.58% / 7.39% |
Non-scoringCDNA / S&P -6.14% / 11.60% | Non-scoringCDNA / S&P CDNA unavailable / 30.50 | Non-scoringCDNA / S&P 7.50 / 4.23 | Non-scoringCDNA / S&P CDNA unavailable / $3.63m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.10b |
| 2020-Q43/3 |
WinCDNA / S&P 90.96% / 12.15% |
WinCDNA / S&P 51.25% / -3.72% |
WinCDNA / S&P -19.23% / -33.42% |
Non-scoringCDNA / S&P -9.74% / 8.86% | Non-scoringCDNA / S&P CDNA unavailable / 39.26 | Non-scoringCDNA / S&P 12.90 / 4.05 | Non-scoringCDNA / S&P CDNA unavailable / $3.17m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.01b |
| 2020-Q32/3 |
LoseCDNA / S&P 7.08% / 8.93% |
WinCDNA / S&P 47.59% / -2.04% |
WinCDNA / S&P 0.00% / -27.10% |
Non-scoringCDNA / S&P -11.79% / 9.24% | Non-scoringCDNA / S&P CDNA unavailable / 34.27 | Non-scoringCDNA / S&P 6.94 / 3.65 | Non-scoringCDNA / S&P CDNA unavailable / $3.17m | Non-scoringCDNA / S&P CDNA unavailable / $0.02b | Non-scoringCDNA / S&P CDNA unavailable / $0.00b |
| 2020-Q22/3 |
WinCDNA / S&P 62.30% / 20.54% |
WinCDNA / S&P 46.69% / -0.46% |
LoseCDNA / S&P -54.17% / -27.11% |
Non-scoringCDNA / S&P -12.66% / 9.37% | Non-scoringCDNA / S&P CDNA unavailable / 31.29 | Non-scoringCDNA / S&P 6.64 / 3.44 | Non-scoringCDNA / S&P CDNA unavailable / $3.17m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.03b |
| 2020-Q12/3 |
WinCDNA / S&P 1.21% / -19.60% |
WinCDNA / S&P 57.59% / 3.47% |
LoseCDNA / S&P -58.97% / -14.75% |
Non-scoringCDNA / S&P -14.53% / 10.68% | Non-scoringCDNA / S&P CDNA unavailable / 22.80 | Non-scoringCDNA / S&P 9.26 / 2.92 | Non-scoringCDNA / S&P CDNA unavailable / $3.17m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.05b |
| 2019-Q41/3 |
LoseCDNA / S&P -4.60% / 9.07% |
WinCDNA / S&P 65.95% / 5.36% |
LoseCDNA / S&P -59.69% / 2.99% |
Non-scoringCDNA / S&P -17.29% / 12.81% | Non-scoringCDNA / S&P CDNA unavailable / 22.78 | Non-scoringCDNA / S&P 9.26 / 3.53 | Non-scoringCDNA / S&P CDNA unavailable / $3.08m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.05b |
| 2019-Q31/3 |
LoseCDNA / S&P -37.18% / 1.70% |
WinCDNA / S&P 75.03% / 5.02% |
LoseCDNA / S&P -81.82% / 0.21% |
Non-scoringCDNA / S&P -18.25% / 12.41% | Non-scoringCDNA / S&P CDNA unavailable / 22.44 | Non-scoringCDNA / S&P 9.83 / 3.30 | Non-scoringCDNA / S&P CDNA unavailable / $3.08m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.09b |
| 2019-Q22/3 |
WinCDNA / S&P 14.18% / 4.30% |
WinCDNA / S&P 80.54% / 6.64% |
LoseCDNA / S&P -63.36% / 8.65% |
Non-scoringCDNA / S&P -38.29% / 12.79% | Non-scoringCDNA / S&P CDNA unavailable / 21.37 | Non-scoringCDNA / S&P 16.34 / 3.32 | Non-scoringCDNA / S&P CDNA unavailable / $3.08m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.27b |
| 2019-Q12/3 |
WinCDNA / S&P 25.38% / 13.65% |
WinCDNA / S&P 74.23% / 8.12% |
LoseCDNA / S&P -51.45% / 14.29% |
Non-scoringCDNA / S&P -51.21% / 12.97% | Non-scoringCDNA / S&P CDNA unavailable / 20.86 | Non-scoringCDNA / S&P 13.82 / 3.26 | Non-scoringCDNA / S&P CDNA unavailable / $3.08m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $34.35b |
| 2018-Q42/3 |
WinCDNA / S&P -12.86% / -13.52% |
WinCDNA / S&P 58.45% / 9.05% |
LoseCDNA / S&P -45.57% / 18.23% |
Non-scoringCDNA / S&P -61.06% / 13.10% | Non-scoringCDNA / S&P CDNA unavailable / 19.39 | Non-scoringCDNA / S&P 10.85 / 2.94 | Non-scoringCDNA / S&P CDNA unavailable / $3.00m | Non-scoringCDNA / S&P CDNA unavailable / $0.01b | Non-scoringCDNA / S&P CDNA unavailable / $0.00b |
| 2018-Q33/3 |
WinCDNA / S&P 135.70% / 7.71% |
WinCDNA / S&P 40.45% / 10.21% |
WinCDNA / S&P 36.02% / 19.06% |
Non-scoringCDNA / S&P -113.89% / 13.01% | Non-scoringCDNA / S&P CDNA unavailable / 22.25 | Non-scoringCDNA / S&P 25.21 / 3.45 | Non-scoringCDNA / S&P CDNA unavailable / $3.00m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.17b |
| 2018-Q23/3 |
WinCDNA / S&P 53.58% / 3.43% |
WinCDNA / S&P 20.45% / 9.03% |
WinCDNA / S&P 75.84% / 14.46% |
Non-scoringCDNA / S&P -121.92% / 12.56% | Non-scoringCDNA / S&P CDNA unavailable / 22.49 | Non-scoringCDNA / S&P 15.21 / 3.25 | Non-scoringCDNA / S&P CDNA unavailable / $3.00m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.19b |
| 2018-Q13/3 |
WinCDNA / S&P 8.58% / -0.76% |
WinCDNA / S&P 11.26% / 7.68% |
WinCDNA / S&P 16.43% / 12.46% |
Non-scoringCDNA / S&P -115.91% / 12.27% | Non-scoringCDNA / S&P CDNA unavailable / 23.41 | Non-scoringCDNA / S&P 8.41 / 3.17 | Non-scoringCDNA / S&P CDNA unavailable / $3.00m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.08b |
| 2017-Q42/3 |
WinCDNA / S&P 98.38% / 6.64% |
WinCDNA / S&P 18.93% / 7.03% |
LoseCDNA / S&P -9.54% / 13.82% |
Non-scoringCDNA / S&P -114.79% / 12.09% | Non-scoringCDNA / S&P CDNA unavailable / 24.25 | Non-scoringCDNA / S&P CDNA unavailable / 3.23 | Non-scoringCDNA / S&P CDNA unavailable / $2.92m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.05b |
| 2017-Q32/3 |
WinCDNA / S&P 233.33% / 4.48% |
WinCDNA / S&P 28.17% / 5.68% |
LoseCDNA / S&P -16.96% / 17.57% |
Non-scoringCDNA / S&P -84.14% / 12.04% | Non-scoringCDNA / S&P CDNA unavailable / 23.28 | Non-scoringCDNA / S&P CDNA unavailable / 3.08 | Non-scoringCDNA / S&P CDNA unavailable / $2.92m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.11b |
| 2017-Q21/3 |
LoseCDNA / S&P -20.71% / 3.09% |
WinCDNA / S&P 51.03% / 4.83% |
LoseCDNA / S&P -34.36% / 17.74% |
Non-scoringCDNA / S&P -61.27% / 11.96% | Non-scoringCDNA / S&P CDNA unavailable / 23.40 | Non-scoringCDNA / S&P 2.01 / 3.03 | Non-scoringCDNA / S&P CDNA unavailable / $2.92m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.08b |
| 2017-Q12/3 |
LoseCDNA / S&P -48.15% / 6.07% |
WinCDNA / S&P 66.07% / 3.67% |
WinCDNA / S&P 16.95% / 13.32% |
Non-scoringCDNA / S&P -77.27% / 11.75% | Non-scoringCDNA / S&P CDNA unavailable / 23.60 | Non-scoringCDNA / S&P 2.04 / 3.01 | Non-scoringCDNA / S&P CDNA unavailable / $2.92m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $20.24b |
| 2016-Q41/3 |
LoseCDNA / S&P -23.94% / 3.82% |
WinCDNA / S&P 44.37% / 2.09% |
LoseCDNA / S&P CDNA unavailable / 7.05% |
Non-scoringCDNA / S&P -97.13% / 11.37% | Non-scoringCDNA / S&P CDNA unavailable / 23.76 | Non-scoringCDNA / S&P 2.95 / 2.91 | Non-scoringCDNA / S&P CDNA unavailable / $2.88m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $1.11b |
| 2016-Q31/3 |
LoseCDNA / S&P -17.63% / 3.85% |
WinCDNA / S&P 23.68% / 0.20% |
LoseCDNA / S&P CDNA unavailable / -3.15% |
Non-scoringCDNA / S&P -78.93% / 10.82% | Non-scoringCDNA / S&P CDNA unavailable / 24.22 | Non-scoringCDNA / S&P 2.08 / 2.78 | Non-scoringCDNA / S&P CDNA unavailable / $2.88m | Non-scoringCDNA / S&P CDNA unavailable / $0.00b | Non-scoringCDNA / S&P CDNA unavailable / $0.16b |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CDNA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 283.31% | 20.78% |
| Annualized return | 283.31% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | CDNA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -30.63% | 83.14% |
| Annualized return | -7.05% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | CDNA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 1058.41% | 319.30% |
| Annualized return | 27.76% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
- Net margin, P/E, P/B and other gray context columns never enter the score.
Snapshot captured 2026-09-04.